Zeke Capital Advisors, LLC Abb Vie Inc. Transaction History

Zeke Capital Advisors, LLC

$1.53 Billion
Q4 2022

A detailed history of Zeke Capital Advisors, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Zeke Capital Advisors, LLC holds 11,916 shares of ABBV stock, worth $2.14 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares

11,916

Previous 10,989 8.44%

Holding current value

$2.14 Million

Previous $1.48 Million 30.58%

% of portfolio

0.13%

Previous 0.11%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$138.31 - $165.87 $128,213 - $153,761	927 Added 8.44%	11,916 $1.93 Million
Q3 2022 Nov 14, 2022	SELL	$134.21 - $153.93 $2,415 - $2,770	-18 Reduced 0.16%	10,989 $1.48 Million
Q2 2022 Aug 09, 2022	BUY	$137.62 - $174.96 $43,350 - $55,112	315 Added 2.95%	11,007 $1.69 Million
Q1 2022 May 13, 2022	BUY	$131.98 - $163.75 $1.19 Million - $1.48 Million	9,018 Added 538.71%	10,692 $1.73 Million
Q4 2021 Feb 14, 2022	BUY	$107.43 - $135.93 $179,837 - $227,546	1,674 New	1,674 $227,000
Q2 2020 Jul 21, 2020	SELL	$73.37 - $98.18 $640,520 - $857,111	-8,730 Closed	0 $0
Q1 2020 Apr 24, 2020	SELL	$64.5 - $97.79 $1.16 Million - $1.76 Million	-18,004 Reduced 67.34%	8,730 $665,000
Q4 2019 Jan 17, 2020	BUY	$72.13 - $90.25 $92,398 - $115,610	1,281 Added 5.03%	26,734 $2.37 Million
Q3 2019 Oct 18, 2019	SELL	$62.98 - $75.72 $562,348 - $676,103	-8,929 Reduced 25.97%	25,453 $1.93 Million
Q2 2019 Jul 24, 2019	SELL	$65.7 - $83.98 $60,049 - $76,757	-914 Reduced 2.59%	34,382 $2.5 Million
Q1 2019 Apr 29, 2019	BUY	$77.14 - $90.79 $381,920 - $449,501	4,951 Added 16.32%	35,296 $2.84 Million
Q4 2018 Feb 11, 2019	BUY	$77.85 - $96.01 $643,041 - $793,042	8,260 Added 37.4%	30,345 $2.8 Million
Q3 2018 Nov 08, 2018	BUY	$88.91 - $98.84 $36,453 - $40,524	410 Added 1.89%	22,085 $2.09 Million
Q2 2018 Jul 24, 2018	SELL	$89.78 - $106.23 $1.13 Million - $1.33 Million	-12,540 Reduced 36.65%	21,675 $2.01 Million
Q1 2018 May 03, 2018	BUY	$92.01 - $123.21 $335,744 - $449,593	3,649 Added 11.94%	34,215 $3.24 Million
Q4 2017 Feb 14, 2018	BUY	$89.56 - $98.21 $454,337 - $498,219	5,073 Added 19.9%	30,566 $2.96 Million
Q3 2017 Nov 09, 2017	BUY	$69.85 - $89.22 $1.78 Million - $2.27 Million	25,493	25,493 $2.27 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Zeke Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Zeke Capital Advisors, LLC with notifications on news.

Account

Zeke Capital Advisors, LLC Abb Vie Inc. Transaction History